Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page
- Check7 days agoChange DetectedThe page's revision tag has been updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a minor update to the page version. No substantive study content is changed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedFooter updates add references to the Moffitt Clinical Trials website and H. Lee Moffitt Cancer Center and Research Institute, along with a 'Helpful Links Provided by' note. The revision marker now shows v3.6.3, replacing the previous v3.6.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, signaling a small maintenance release and version tracking for the study page.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded new user-help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated recruitment status to No longer looking for participants. Included a Revision: v3.6.0 and minor formatting adjustments to the Intervention/Treatment header.SummaryDifference0.4%

- Check57 days agoChange DetectedThe page now displays revision v3.5.5, replacing the prior v3.5.4. This represents a minor administrative update to the page metadata rather than changes to study details.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter branding and navigation elements were removed, including the Moffitt trial website link, sponsor name, and the 'Helpful Links Provided by' header. This changes how the page footer presents branding and navigation but does not alter the study details.SummaryDifference0.2%

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.